Skip to main content

Grafa News and Videos — Page 1627

Latest

Grafa

Pharming receives positive CHMP opinion for Joenja to treat rare primary immunodeficiency

Pharming Group (NASDAQ:PHAR), a global biopharmaceutical company dedicated to transforming the lives of patients with rare diseases, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion.

Read more: Pharming receives positive CHMP opinion for Joenja to treat rare primary immunodeficiency

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift